News & Updates
Excerpt from the article: “VANCOUVER—A Canadian biotech company says it’s well on its way to developing a treatment for COVID-19 that could help save the lives of those most vulnerable to the virus. And Carl Hansen’s AbCellera Biologics Inc. now has a $175-million vote of confidence from the federal government.” Click the button below to…
Read More
Excerpt from the article: “Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic.” Click the button below to read the article:…
Read More
Excerpt from the article: A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19. “The animals were infected with the novel coronavirus, SARS-CoV-2. Data announced by the National Institutes of Health (NIH) revealed a significant decrease in clinical disease and reduced lung…
Read More
Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…
Read More
J&J is launching a new video series documenting their process towards developing a vaccine for COVID-19. Excerpt from their announcement: “This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine. Each week our host Lisa Ling will talk…
Read More
Excerpt from the press release: “PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune…
Read More
Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…
Read More
Excerpt From the Article: Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic. Sean Tucker, Vaxart’s chief scientific officer, said the…
Read More
Excerpt from the article: April 23, 2020 — Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had symptoms longer than 48 hours, according to a study published April 21 in Radiology: Cardiothoracic Imaging. The results are good news…
Read More
Excerpt From the Article: Researchers at the Swiss Federal Laboratory have developed a sensor that could potentially quickly and reliably detect SARS-CoV-2, the COVID-19 virus. Prior to the coronavirus spreading around the world, Jing Wang and his colleagues were researching sensors that could detect bacteria and viruses in the air. The concept of the sensor…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?